Butalid, Resciel C.
HRN: 27-65-02 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/21/2025
CLINDAMYCIN 150MG/ML, 4ML (AMP)
10/21/2025
10/27/2025
IV
600 Mg
Q8hr
SSI
Waiting Final Action
10/22/2025
MUPIROCIN 2%, 15G (TUBE)
10/22/2025
10/28/2025
TOPICAL
1ml
TID
SSI
Waiting Final Action